Crossmark

Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients

Published Online: 2020-08-12

Published Print: 2020-12

Authors

Hifumi, Toru http://orcid.org/0000-0002-9627-3702
Isokawa, Shutaro

Otani, Norio

Ishimatsu, Shinichi
License Information

Text and Data Mining valid from 2020-08-12

Version of Record valid from 2020-08-12
More Information

Article History

Received: 14 July 2020

Accepted: 5 August 2020

First Online: 12 August 2020

Ethics approval and consent to participate

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

Document is current